[The prevention of thromboembolic disease in medical patients: heparin-calcium or low-molecular-weight heparin?].
de los Santos-Sastre
S
S
D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000517:prevention & control*
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; C006871:calcium heparin; D006493:Heparin
Profilaxis de la enfermedad tromboembólica en pacientes médicos: heparina cálcica o heparina de bajo peso molecular?